These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15002360)

  • 21. Aggressive drug marketing tactics trigger backlash.
    Singer E
    Nat Med; 2007 Apr; 13(4):393. PubMed ID: 17415363
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ascending curves of new products: an instrument of marketing].
    Barocco V
    Boll Chim Farm; 1976 Jul; 115(7):529-37. PubMed ID: 1016609
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of quality, capacity, and productivity at Merck.
    Nathan J; Venkataraman R
    Hosp Mater Manage Q; 1999 Feb; 20(3):64-9. PubMed ID: 10345635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine.
    Finkel AG
    Headache; 2006; 46(7):1181-5. PubMed ID: 16866722
    [No Abstract]   [Full Text] [Related]  

  • 25. Closing the sample closet.
    Brewer B
    Fam Pract Manag; 2006; 13(10):16; author reply 21. PubMed ID: 17144004
    [No Abstract]   [Full Text] [Related]  

  • 26. US drug industry bans expensive freebies for MDs, Canada raises fines.
    Sibbald B
    CMAJ; 2002 Sep; 167(5):522. PubMed ID: 12240824
    [No Abstract]   [Full Text] [Related]  

  • 27. [Marketing makes pressure! ACE inhibitors or AT2? We must choose...].
    Jolidon RM
    Rev Med Suisse; 2006 Oct; 2(83):2372-3; author reply 2373. PubMed ID: 17112090
    [No Abstract]   [Full Text] [Related]  

  • 28. Saving the sample closet.
    Taylor JA
    Fam Pract Manag; 2007 Jan; 14(1):11. PubMed ID: 17294975
    [No Abstract]   [Full Text] [Related]  

  • 29. Closing the sample closet.
    Johnson JE
    Fam Pract Manag; 2006; 13(10):16, 21; author reply 21. PubMed ID: 17144006
    [No Abstract]   [Full Text] [Related]  

  • 30. The physician's stake in health care marketing.
    Fink DJ
    Hosp Med Staff; 1981 Apr; 10(4):2-8. PubMed ID: 10250716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Benzodiazepines. Physicians in the public service and industry: time to take responsibility for abuse of the drug].
    Sjöberg C
    Lakartidningen; 1993 Apr; 90(17):1670, 1675. PubMed ID: 8487614
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug firms cut doctors' fees for drug talks.
    McCarthy M
    BMJ; 2014 Mar; 348():g2021. PubMed ID: 24607478
    [No Abstract]   [Full Text] [Related]  

  • 33. Challenges and a new vision for academic surgery.
    Cobb JP; Warner BW
    J Am Coll Surg; 2005 Apr; 200(4):605-6. PubMed ID: 15804475
    [No Abstract]   [Full Text] [Related]  

  • 34. Curbing industry sponsor's incentive to design post-approval trials that are suboptimal for informing prescribers but more likely than optimal designs to yield favorable results.
    Falit BP
    Seton Hall Law Rev; 2007; 37(4):969-1049. PubMed ID: 18363220
    [No Abstract]   [Full Text] [Related]  

  • 35. The changing relationship between health care professionals and the pharmaceutical industry.
    Arriola E
    Hosp Formul; 1995 Mar; 30(3):161-5; discussion 163-9. PubMed ID: 10141248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Closing the sample closet.
    Sanders J
    Fam Pract Manag; 2006; 13(10):16, 21; author reply 21. PubMed ID: 17144005
    [No Abstract]   [Full Text] [Related]  

  • 37. Economic and policy implications of reimportation: a Canadian perspective.
    Ward C
    Manag Care; 2004 Mar; 13(3 Suppl):17-20. PubMed ID: 15074165
    [No Abstract]   [Full Text] [Related]  

  • 38. [Physicians' influence on the "drug market"].
    Paprocki M
    Pol Tyg Lek; 1982 Jun; 37(19-20):585-7. PubMed ID: 7177953
    [No Abstract]   [Full Text] [Related]  

  • 39. Most drug freebies go to well-off: study. Research suggests race, gender a factor, too, but drug group calls research flawed.
    Rhea S
    Mod Healthc; 2008 Jan; 38(1):12-3. PubMed ID: 18273965
    [No Abstract]   [Full Text] [Related]  

  • 40. Informed consent and generic drug substitution.
    DeVeaugh-Geiss J
    Clin Ther; 1985; 7(5):544-8. PubMed ID: 4053144
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.